The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding Company (ASE:JPHM)

Jordan · Delayed Price · Currency is JOD

1.480

0.00 (0.00%)

At close: Aug 24, 2026

ASE:JPHM Financials Overview

Financials in millions JOD. Fiscal year is January - December.

Millions JOD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	24.46	16.86	14.58	16.96	15.83	14.92
Revenue Growth	59.75%	15.65%	-14.03%	7.16%	6.12%	49.49%
Gross Profit	12.4	7.08	3.57	6.86	5.04	4.99
Operating Income	5.5	0.29	-2.01	-0.88	-2.61	-2.99
Net Income	4.86	0.65	-2.86	0.22	0.12	-11.64
Earnings Per Share	0.14	0.02	-0.08	0.00	0.00	-0.46
EPS Growth	-	-	-	79.56%	-	-

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Jordan	9.25	9.29	7.68	7.64	7.34	6.01
Outside Jordan	15.21	7.57	6.9	9.32	8.49	8.91
Total	24.46	16.86	14.58	16.96	15.83	14.92

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	0.13	0.05	0.62	2.61	11.43	0.21
Total Debt	28.35	32.76	33.67	35.43	36.94	34.43
Net Cash (Debt)	-28.22	-32.71	-33.05	-32.82	-25.51	-34.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.84	-0.97	-0.98	-0.48	-0.37	-1.35

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	5.65	2.43	1.4	-5.59	-0.03	-9.47
Capital Expenditures	-1.39	-1.45	-1	-1.01	-0.29	-0.19
Free Cash Flow	4.26	0.98	0.4	-6.59	-0.32	-9.66
Free Cash Flow Growth	186.33%	144.92%	-	-	-	-

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	50.68%	42.00%	24.51%	40.42%	31.85%	33.45%
Operating Margin	22.48%	1.71%	-13.77%	-5.17%	-16.48%	-20.07%
Pretax Margin	23.98%	5.81%	-18.58%	-5.44%	0.95%	-64.22%
Profit Margin	19.88%	3.86%	-19.59%	1.29%	0.77%	-78.02%
FCF Margin	17.43%	5.82%	2.75%	-38.88%	-2.02%	-64.79%

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PE Ratio	10.26	-	-	-	49.76	-
Forward PE	-	19.00	19.00	19.00	19.00	19.00
PS Ratio	2.75	-	-	-	0.38	0.41